Roghani, Mehrdad <br/><br/>
Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.  [electronic resource] 

 -  Brain research bulletin  Jul 2010 
 - 279-83 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2747 
<br/><br/><label>Standard No.: </label>10.1016/j.brainresbull.2010.06.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Anthocyanins--administration & dosage<br/>Antiparkinson Agents--pharmacology<br/>Apomorphine--pharmacology<br/>Cell Count--methods<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Functional Laterality--drug effects<br/>Lipid Peroxidation--drug effects<br/>Male<br/>Mesencephalon--drug effects<br/>Neurons--drug effects<br/>Neuroprotective Agents--administration & dosage<br/>Nitric Oxide--metabolism<br/>Oxidopamine<br/>Parkinsonian Disorders--chemically induced<br/>Rats<br/>Rats, Wistar<br/>Statistics, Nonparametric<br/>Superoxide Dismutase--metabolism<br/>Thiobarbituric Acid Reactive Substances--metabolism